DNA Link Inc
KOSDAQ:127120
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DNA Link Inc
Cash from Investing Activities
DNA Link Inc
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DNA Link Inc
KOSDAQ:127120
|
Cash from Investing Activities
-₩33.4B
|
CAGR 3-Years
-132%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Celltrion Inc
KRX:068270
|
Cash from Investing Activities
-₩860.4B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-19%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Cash from Investing Activities
-₩104.9B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Cash from Investing Activities
₩22.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Cash from Investing Activities
-₩231.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-49%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Cash from Investing Activities
₩62.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DNA Link Inc
Glance View
DNA Link, Inc. provides genomic analysis services. The company is headquartered in Seoul, Seoul. The company went IPO on 2011-12-26. The firm provides genome biomarkers excavation products through integrated genomic analysis and integrated clinical information analysis including high-quality data products according to genomic analysis, interpretation of analysis results, and technologies of molecular diagnostic kit production under the brand name of enhanced genome integration system (EGIS). The firm also provides personal genome analysis service products under the brand name of deoxyribonucleic acid personalized services (DNAGPS).
See Also
What is DNA Link Inc's Cash from Investing Activities?
Cash from Investing Activities
-33.4B
KRW
Based on the financial report for Dec 31, 2025, DNA Link Inc's Cash from Investing Activities amounts to -33.4B KRW.
What is DNA Link Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-10%
Over the last year, the Cash from Investing Activities growth was -80%. The average annual Cash from Investing Activities growth rates for DNA Link Inc have been -132% over the past three years , and -10% over the past ten years .
